4//SEC Filing
Forte Steve 4
Accession 0001415889-25-007237
CIK 0001808158other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 5:00 PM ET
Size
10.0 KB
Accession
0001415889-25-007237
Insider Transaction Report
Form 4
Forte Steve
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Shares
2025-03-04+14,000→ 61,670 total - Award
Employee Stock Option (right to buy)
2025-03-04+200,000→ 200,000 totalExercise: $1.17Exp: 2035-03-03→ Common Shares (200,000 underlying) - Award
Employee Stock Option (right to buy)
2025-03-04+85,000→ 85,000 totalExercise: $1.17Exp: 2035-03-03→ Common Shares (85,000 underlying)
Footnotes (4)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of March 4, 2026, March 4, 2027 and March 4, 2028, subject to Reporting Person continuing to provide service through each such date.
- [F2]Includes 895 and 2,000 shares acquired on August 15, 2024 and February 15, 2025, respectively, under the Issuer's employee stock purchase plan.
- [F3]The option will vest in in full on March 4, 2026, subject to Reporting Person continuing to provide service through such date.
- [F4]Twenty-five percent (25%) of the shares subject to the option shall vest on March 4, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Repare Therapeutics Inc.
CIK 0001808158
Entity typeother
Related Parties
1- filerCIK 0001815428
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 5:00 PM ET
- Size
- 10.0 KB